HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SINOMAB BIO-B

1.100

+0.0252.33%

Volume:666.00K

Turnover:709.51K

Market Cap:1.53B

PE:-11.02

High:1.120

Open:1.075

Low:1.030

Close:1.075

52wk High:2.740

52wk Low:0.990

Shares:1.39B

HK Float Shares:1.39B

Volume Ratio:0.90

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.100

ROE:-29.96%

ROA:-9.63%

PB:2.57

PE(LYR):-11.02

PS:228.33

Loading ...

Overview Company News Filings

Sinomab Bioscience Maintains 1.39 Billion Outstanding Shares in March 2026, Grants 11.57 Million New Options

Bulletin Express

BRIEF-Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience

Hainan Haiyao Says Co Plans to Unload up to 5% Stake in SinoMab BioScience Ltd

THOMSON REUTERS

SM17 Phase 2 Trial for Atopic Dermatitis Administers First Dose in China

SinoMab doses first patient in China Phase 2 trial of SM17 for atopic dermatitis

SinoMab BioScience says non-executive directors Chen, Dong resign

SinoMab BioScience files list of directors with Hong Kong Stock Exchange

SinoMab Announces Resignation of Two Non-Executive Directors Effective March–April 2026

Bulletin Express

SinoMab Announces Updated Board Composition and Committee Assignments

Bulletin Express

SINOMAB BIO-B Announces Resignation of Non-Executive Director

SinoMab Announces Positive Phase 1 Bridging Data for Subcutaneous SM17, Preparing Phase 2 Atopic Dermatitis Trial

Bulletin Express

Positive Topline Results from SM17 Route Conversion Phase 1 Bridging Study in China

SinoMab BioScience announces positive topline results for SM17 China Phase 1 route-switch bridging study; AD Phase 2 in China expected to start by mid-FY2026

SINOMAB BIO-B (03681) Grants 11.5748 Million Share Options

SinoMab Grants 11.57 Million Share Options at HK$1.94 to Two Employees, Including One Senior Manager

Bulletin Express

SinoMab grants 11,574,840 share options at HKD 1.94 per share

SinoMab BioScience's 2025 Loss Narrows

MT Newswires Live

BRIEF-Sinomab Bioscience Posts Loss For Year Rmb105.0 Million

SINOMAB BIO-B (03681) Reports Significant Narrowing of Losses in 2025, Major Strides in Pipeline Development and Commercialization

SinoMab FY2025 loss narrows 43.3% to RMB105 million, total funding available jumps 148.5% to RMB351 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/03681/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03681","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03681\",,,,,undefined,":{"symbol":"03681","market":"HK","secType":"STK","nameCN":"SINOMAB BIO-B","latestPrice":1.1,"timestamp":1788163726679,"preClose":1.075,"halted":0,"volume":666000,"delay":0,"changeRate":0.023255813953488497,"floatShares":1387000000,"shares":1387000000,"eps":-0.0998152763672564,"marketStatus":"Not Yet Opened","change":0.025,"latestTime":"08-31 16:08:46","open":1.075,"high":1.12,"low":1.03,"amount":709509,"amplitude":0.083721,"askPrice":1.115,"askSize":60000,"bidPrice":1.1,"bidSize":234900,"shortable":0,"etf":0,"ttmEps":-0.0980091085104215,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1573488000000,"exchange":"SEHK","adjPreClose":1.075,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.8979856000521773,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03681\",,,,,undefined,":{"symbol":"03681","floatShares":1387000000,"roa":"-9.63%","roe":"-29.96%","lyrEps":-0.099815,"volumeRatio":0.8979856000521773,"shares":1387000000,"dividePrice":0,"high":1.12,"amplitude":0.083721,"preClose":1.075,"low":1.03,"week52Low":0.99,"pbRate":"2.57","psRate":"228.33","week52High":2.74,"institutionHeld":0,"latestPrice":1.1,"committee":0.593082,"eps":-0.0998152763672564,"divideRate":0,"volume":666000,"delay":0,"ttmEps":-0.0980091085104215,"open":1.075,"prevYearClose":1.34,"prevWeekClose":1.075,"prevMonthClose":1.1,"prevQuarterClose":1.01,"fiveDayClose":1.11,"twentyDayClose":1.355,"sixtyDayClose":1.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03681\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-23","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-29","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null},{"date":"2025-03-31","symbol":"03681","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"Post-Mkt","dateTimestamp":1743350400000,"actualEps":null},{"date":"2024-08-19","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03681\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03681\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03681\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03681","date":"2026-08-28","current":-11.22933,"percent":0.341709,"low":-23.455488,"twenty":-14.61481,"median":-6.562246,"eighty":-5.465196,"high":-3.722923,"avg":-9.290297,"sd":4.69913,"marketCap":1490636211},"quantilePoints":[{"date":"2021-09-03","current":-17.554902,"twenty":-14.338065,"median":-12.760766,"eighty":-11.775878,"marketCap":3300468512},{"date":"2021-09-10","current":-16.976031,"twenty":-17.456016,"median":-12.775475,"eighty":-11.78116,"marketCap":3199844472},{"date":"2021-09-17","current":-16.651593,"twenty":-17.163126,"median":-12.813689,"eighty":-11.784078,"marketCap":3129407644},{"date":"2021-09-24","current":-16.322789,"twenty":-17.01345,"median":-12.863899,"eighty":-11.803908,"marketCap":3069033220},{"date":"2021-09-30","current":-15.62828,"twenty":-16.889918,"median":-12.933105,"eighty":-11.815139,"marketCap":2948284372},{"date":"2021-10-08","current":-15.255604,"twenty":-16.819086,"median":-13.000983,"eighty":-11.827705,"marketCap":2877847544},{"date":"2021-10-15","current":-15.72489,"twenty":-16.74672,"median":-13.132604,"eighty":-11.837118,"marketCap":2968409180},{"date":"2021-10-22","current":-15.401098,"twenty":-16.540959,"median":-13.171977,"eighty":-11.85164,"marketCap":2928159564},{"date":"2021-10-29","current":-15.227051,"twenty":-16.374107,"median":-13.199196,"eighty":-11.878327,"marketCap":2887909948},{"date":"2021-11-05","current":-14.725283,"twenty":-16.372621,"median":-13.237809,"eighty":-11.89956,"marketCap":2797348312},{"date":"2021-11-12","current":-14.61207,"twenty":-16.352569,"median":-13.315659,"eighty":-11.914333,"marketCap":2787285908},{"date":"2021-11-19","current":-15.742119,"twenty":-16.272521,"median":-13.361795,"eighty":-11.935532,"marketCap":2998596392},{"date":"2021-11-26","current":-16.370792,"twenty":-16.351591,"median":-13.392935,"eighty":-11.980901,"marketCap":3119345240},{"date":"2021-12-03","current":-15.286348,"twenty":-16.351591,"median":-13.405799,"eighty":-12.04665,"marketCap":2918097160},{"date":"2021-12-10","current":-15.733887,"twenty":-16.272521,"median":-13.447456,"eighty":-12.050361,"marketCap":3008658796},{"date":"2021-12-17","current":-15.639454,"twenty":-16.187564,"median":-13.518433,"eighty":-12.058984,"marketCap":2988533988},{"date":"2021-12-24","current":-14.782807,"twenty":-16.164329,"median":-13.528315,"eighty":-12.072918,"marketCap":2827535524},{"date":"2021-12-31","current":-15.013189,"twenty":-16.148278,"median":-13.610066,"eighty":-12.088245,"marketCap":2877847544},{"date":"2022-01-07","current":-15.18328,"twenty":-56.995184,"median":-15.257327,"eighty":-11.069992,"marketCap":2897972352},{"date":"2022-01-14","current":-13.838759,"twenty":-56.661206,"median":-15.253171,"eighty":-11.083158,"marketCap":2646412252},{"date":"2022-01-21","current":-14.011082,"twenty":-56.563091,"median":-15.205087,"eighty":-11.097021,"marketCap":2686661868},{"date":"2022-01-28","current":-13.844706,"twenty":-56.416081,"median":-15.162616,"eighty":-11.110592,"marketCap":2646412252},{"date":"2022-02-04","current":-14.147107,"twenty":-56.354717,"median":-15.132267,"eighty":-11.116336,"marketCap":2706786676},{"date":"2022-02-11","current":-14.606007,"twenty":-56.147197,"median":-15.118177,"eighty":-11.129988,"marketCap":2797348312},{"date":"2022-02-18","current":-14.139516,"twenty":-55.690459,"median":-15.086325,"eighty":-11.142948,"marketCap":2716849080},{"date":"2022-02-25","current":-13.42323,"twenty":-55.257879,"median":-15.019949,"eighty":-11.15276,"marketCap":2586037828},{"date":"2022-03-04","current":-13.026991,"twenty":-53.858211,"median":-14.992767,"eighty":-11.16401,"marketCap":2515601000},{"date":"2022-03-11","current":-11.331852,"twenty":-51.77227,"median":-14.946362,"eighty":-11.15276,"marketCap":2183541668},{"date":"2022-03-18","current":-10.950696,"twenty":-51.706305,"median":-14.891162,"eighty":-11.138994,"marketCap":2103042436},{"date":"2022-03-25","current":-6.331043,"twenty":-51.516242,"median":-14.885049,"eighty":-11.102449,"marketCap":2243916092},{"date":"2022-04-01","current":-6.444111,"twenty":-51.096665,"median":-14.824593,"eighty":-11.058409,"marketCap":2294228112},{"date":"2022-04-08","current":-6.459624,"twenty":-46.359849,"median":-14.790242,"eighty":-11.033253,"marketCap":2294228112},{"date":"2022-04-14","current":-5.956258,"twenty":-29.052376,"median":-14.738629,"eighty":-11.016253,"marketCap":2113104840},{"date":"2022-04-22","current":-6.201306,"twenty":-29.037222,"median":-14.692829,"eighty":-10.958063,"marketCap":2173479264},{"date":"2022-04-29","current":-7.047751,"twenty":-28.4902,"median":-14.61207,"eighty":-10.874053,"marketCap":2404914556},{"date":"2022-05-06","current":-7.40055,"twenty":-28.325538,"median":-14.600612,"eighty":-10.804339,"marketCap":2515601000},{"date":"2022-05-13","current":-6.941182,"twenty":-28.290262,"median":-14.594456,"eighty":-10.722043,"marketCap":2314352920},{"date":"2022-05-20","current":-7.047867,"twenty":-28.237839,"median":-14.568039,"eighty":-10.643776,"marketCap":2374727344},{"date":"2022-05-27","current":-6.144605,"twenty":-28.156235,"median":-14.531177,"eighty":-10.62065,"marketCap":2062792820},{"date":"2022-06-02","current":-6.336579,"twenty":-27.976109,"median":-14.467448,"eighty":-10.551157,"marketCap":2143292052},{"date":"2022-06-10","current":-5.805638,"twenty":-27.48092,"median":-14.330061,"eighty":-10.395661,"marketCap":1962168780},{"date":"2022-06-17","current":-6.023844,"twenty":-27.416382,"median":-14.289989,"eighty":-10.295871,"marketCap":2032605608},{"date":"2022-06-24","current":-5.928927,"twenty":-27.299726,"median":-14.240631,"eighty":-10.21101,"marketCap":2002418396},{"date":"2022-06-30","current":-5.933518,"twenty":-27.286301,"median":-14.178121,"eighty":-10.034927,"marketCap":2002418396},{"date":"2022-07-08","current":-6.051704,"twenty":-27.219437,"median":-14.139516,"eighty":-9.92976,"marketCap":2042668012},{"date":"2022-07-15","current":-6.160189,"twenty":-27.207128,"median":-14.122793,"eighty":-9.645343,"marketCap":2062792820},{"date":"2022-07-22","current":-6.38092,"twenty":-27.106743,"median":-14.101553,"eighty":-9.560125,"marketCap":2133229648},{"date":"2022-07-29","current":-6.359757,"twenty":-26.964443,"median":-14.083303,"eighty":-9.205273,"marketCap":2133229648},{"date":"2022-08-05","current":-6.154173,"twenty":-26.908811,"median":-14.068582,"eighty":-8.936804,"marketCap":2062792820},{"date":"2022-08-29","current":-5.022866,"twenty":-26.892677,"median":-14.039832,"eighty":-8.916691,"marketCap":1821295124},{"date":"2022-09-23","current":-5.142672,"twenty":-26.844273,"median":-13.982946,"eighty":-8.833147,"marketCap":1811232720},{"date":"2022-09-30","current":-5.173446,"twenty":-26.611125,"median":-13.901548,"eighty":-8.524333,"marketCap":1811232720},{"date":"2022-10-07","current":-5.226001,"twenty":-26.521278,"median":-13.841732,"eighty":-8.358846,"marketCap":1831357528},{"date":"2022-10-14","current":-5.210526,"twenty":-26.305402,"median":-13.711835,"eighty":-8.302258,"marketCap":1811232720},{"date":"2022-10-21","current":-5.299371,"twenty":-25.86293,"median":-13.634607,"eighty":-8.237937,"marketCap":1831357528},{"date":"2022-10-28","current":-5.250715,"twenty":-25.481615,"median":-13.551791,"eighty":-8.192941,"marketCap":1811232720},{"date":"2022-11-04","current":-5.746084,"twenty":-25.351843,"median":-13.359927,"eighty":-8.154695,"marketCap":1962168780},{"date":"2022-11-11","current":-5.443671,"twenty":-25.120629,"median":-13.222993,"eighty":-8.092767,"marketCap":1881669548},{"date":"2022-11-18","current":-5.72081,"twenty":-24.878607,"median":-13.14013,"eighty":-8.013993,"marketCap":1987047168},{"date":"2022-11-25","current":-5.519749,"twenty":-24.782531,"median":-13.026991,"eighty":-7.970562,"marketCap":1914602740},{"date":"2022-12-02","current":-5.340737,"twenty":-24.72503,"median":-13.016314,"eighty":-7.221843,"marketCap":1873205924},{"date":"2022-12-09","current":-5.278499,"twenty":-24.658883,"median":-12.887225,"eighty":-7.02693,"marketCap":1873205924},{"date":"2022-12-16","current":-5.377354,"twenty":-24.555217,"median":-12.861423,"eighty":-6.967635,"marketCap":1904253536},{"date":"2022-12-23","current":-5.310796,"twenty":-24.239903,"median":-12.809384,"eighty":-6.931658,"marketCap":1883555128},{"date":"2022-12-30","current":-5.2687,"twenty":-24.19825,"median":-12.751378,"eighty":-6.815448,"marketCap":1873205924},{"date":"2023-01-06","current":-5.684551,"twenty":-24.029078,"median":-12.691232,"eighty":-6.533241,"marketCap":2049142392},{"date":"2023-01-13","current":-6.044097,"twenty":-23.920542,"median":-12.610749,"eighty":-6.476414,"marketCap":2225078860},{"date":"2023-01-20","current":-5.920758,"twenty":-23.91098,"median":-12.476187,"eighty":-6.460592,"marketCap":2173332840},{"date":"2023-01-27","current":-5.929064,"twenty":-23.908935,"median":-12.464745,"eighty":-6.456521,"marketCap":2173332840},{"date":"2023-02-03","current":-5.619442,"twenty":-23.898059,"median":-12.438653,"eighty":-6.416304,"marketCap":2080190004},{"date":"2023-02-10","current":-5.629701,"twenty":-23.856379,"median":-12.391406,"eighty":-6.379809,"marketCap":2069840800},{"date":"2023-02-17","current":-6.151199,"twenty":-23.803856,"median":-12.342203,"eighty":-6.364619,"marketCap":2235428064},{"date":"2023-02-24","current":-5.880578,"twenty":-23.763812,"median":-12.319761,"eighty":-6.355094,"marketCap":2121586820},{"date":"2023-03-03","current":-5.79659,"twenty":-23.726876,"median":-12.282467,"eighty":-6.32688,"marketCap":2090539208},{"date":"2023-03-10","current":-5.984239,"twenty":-5.977251,"median":-5.862778,"eighty":-5.737999,"marketCap":2142285228},{"date":"2023-03-17","current":-5.440145,"twenty":-15.605451,"median":-11.818551,"eighty":-6.319247,"marketCap":1966348760},{"date":"2023-03-24","current":-5.852823,"twenty":-15.553476,"median":-11.796779,"eighty":-6.303621,"marketCap":1914602740},{"date":"2023-03-31","current":-5.770352,"twenty":-15.464387,"median":-11.782619,"eighty":-6.235793,"marketCap":1873205924},{"date":"2023-04-06","current":-6.188789,"twenty":-15.419813,"median":-11.775878,"eighty":-6.2298,"marketCap":2007745576},{"date":"2023-04-14","current":-5.83212,"twenty":-15.401098,"median":-11.743407,"eighty":-6.188789,"marketCap":1893904332},{"date":"2023-04-21","current":-5.803236,"twenty":-15.349971,"median":-11.591935,"eighty":-6.151199,"marketCap":1883555128},{"date":"2023-04-28","current":-5.97527,"twenty":-15.338346,"median":-11.514937,"eighty":-6.125749,"marketCap":1924951944},{"date":"2023-05-05","current":-6.029633,"twenty":-15.318487,"median":-11.456076,"eighty":-6.093971,"marketCap":1945650352},{"date":"2023-05-12","current":-5.845377,"twenty":-15.293441,"median":-11.42324,"eighty":-6.058678,"marketCap":1873205924},{"date":"2023-05-19","current":-5.895989,"twenty":-15.286763,"median":-11.409661,"eighty":-6.038289,"marketCap":1862856720},{"date":"2023-05-25","current":-5.986134,"twenty":-15.285108,"median":-11.402641,"eighty":-6.02786,"marketCap":1883555128},{"date":"2023-06-02","current":-6.039504,"twenty":-15.27892,"median":-11.345627,"eighty":-6.019397,"marketCap":1893904332},{"date":"2023-06-09","current":-5.916028,"twenty":-15.273247,"median":-11.325201,"eighty":-5.997341,"marketCap":1852507516},{"date":"2023-06-16","current":-5.977706,"twenty":-15.264367,"median":-11.276371,"eighty":-5.991274,"marketCap":1862856720},{"date":"2023-06-23","current":-5.910315,"twenty":-15.259114,"median":-11.226206,"eighty":-5.990104,"marketCap":1831809108},{"date":"2023-06-30","current":-5.997962,"twenty":-15.257471,"median":-11.199148,"eighty":-5.991102,"marketCap":1842158312},{"date":"2023-07-07","current":-5.942162,"twenty":-15.252204,"median":-11.17859,"eighty":-5.98564,"marketCap":1821459904},{"date":"2023-07-14","current":-5.959818,"twenty":-15.244629,"median":-11.155312,"eighty":-5.982549,"marketCap":1852507516},{"date":"2023-07-21","current":-5.653141,"twenty":-15.235372,"median":-11.133484,"eighty":-5.979215,"marketCap":1749015476},{"date":"2023-07-28","current":-5.290848,"twenty":-15.218265,"median":-11.083158,"eighty":-5.976244,"marketCap":1635174232},{"date":"2023-08-04","current":-5.34893,"twenty":-15.196364,"median":-11.056497,"eighty":-5.968485,"marketCap":1655872640},{"date":"2023-08-11","current":-4.874993,"twenty":-15.168558,"median":-11.029974,"eighty":-5.961311,"marketCap":1500634580},{"date":"2023-08-18","current":-4.808559,"twenty":-15.136918,"median":-11.016801,"eighty":-5.956293,"marketCap":1469586968},{"date":"2023-08-25","current":-4.590479,"twenty":-15.120821,"median":-10.958733,"eighty":-5.941162,"marketCap":1355745724},{"date":"2023-09-01","current":-4.397014,"twenty":-15.116519,"median":-10.950589,"eighty":-5.933791,"marketCap":1303999704},{"date":"2023-09-08","current":-4.343456,"twenty":-15.110458,"median":-10.924914,"eighty":-5.928982,"marketCap":1272952092},{"date":"2023-09-15","current":-4.239957,"twenty":-15.090079,"median":-10.864295,"eighty":-5.922195,"marketCap":1252253684},{"date":"2023-09-22","current":-4.223382,"twenty":-15.048512,"median":-10.810823,"eighty":-5.914373,"marketCap":1241904480},{"date":"2023-09-29","current":-4.216151,"twenty":-15.017245,"median":-10.782147,"eighty":-5.907939,"marketCap":1241904480},{"date":"2023-10-06","current":-4.112716,"twenty":-15.011235,"median":-10.698286,"eighty":-5.896366,"marketCap":1210856868},{"date":"2023-10-13","current":-3.837237,"twenty":-15.002346,"median":-10.647718,"eighty":-5.882039,"marketCap":1128063236},{"date":"2023-10-20","current":-4.160483,"twenty":-14.995938,"median":-10.633588,"eighty":-5.85882,"marketCap":1221206072},{"date":"2023-10-27","current":-3.950628,"twenty":-14.987484,"median":-10.612846,"eighty":-5.848271,"marketCap":1159110848},{"date":"2023-11-03","current":-3.869806,"twenty":-14.961935,"median":-10.544851,"eighty":-5.844462,"marketCap":1138412440},{"date":"2023-11-10","current":-3.835427,"twenty":-14.946362,"median":-10.425013,"eighty":-5.805638,"marketCap":1128063236},{"date":"2023-11-17","current":-4.010382,"twenty":-14.933379,"median":-10.337162,"eighty":-5.799605,"marketCap":1190158460},{"date":"2023-11-24","current":-4.150577,"twenty":-14.892592,"median":-10.317083,"eighty":-5.770352,"marketCap":1241904480},{"date":"2023-12-01","current":-4.305663,"twenty":-14.891221,"median":-10.26225,"eighty":-5.759604,"marketCap":1293650500},{"date":"2023-12-08","current":-5.118594,"twenty":-14.888832,"median":-10.236073,"eighty":-5.746084,"marketCap":1531682192},{"date":"2023-12-15","current":-5.983256,"twenty":-14.88193,"median":-10.184968,"eighty":-5.726275,"marketCap":1800761496},{"date":"2023-12-22","current":-6.021664,"twenty":-14.863859,"median":-10.158257,"eighty":-5.72081,"marketCap":1811110700},{"date":"2023-12-29","current":-5.750139,"twenty":-14.843956,"median":-10.132916,"eighty":-5.718706,"marketCap":1738666272},{"date":"2024-01-05","current":-5.68757,"twenty":-14.823059,"median":-10.050045,"eighty":-5.707969,"marketCap":1707618660},{"date":"2024-01-12","current":-6.094205,"twenty":-14.80664,"median":-10.01363,"eighty":-5.702385,"marketCap":1830679813},{"date":"2024-01-19","current":-5.813707,"twenty":-14.792628,"median":-10.010505,"eighty":-5.707969,"marketCap":1744020413},{"date":"2024-01-26","current":-5.727669,"twenty":-14.770095,"median":-9.994578,"eighty":-5.702385,"marketCap":1711523138},{"date":"2024-02-02","current":-5.121562,"twenty":-14.746641,"median":-9.9689,"eighty":-5.687475,"marketCap":1528457166},{"date":"2024-02-09","current":-5.096464,"twenty":-14.734149,"median":-9.944662,"eighty":-5.662686,"marketCap":1528457166},{"date":"2024-02-16","current":-5.240944,"twenty":-14.725283,"median":-9.913368,"eighty":-5.653616,"marketCap":1572127371},{"date":"2024-02-23","current":-5.085778,"twenty":-14.723007,"median":-9.893442,"eighty":-5.639193,"marketCap":1517539615},{"date":"2024-03-01","current":-5.009476,"twenty":-14.664467,"median":-9.865328,"eighty":-5.60727,"marketCap":1495704513},{"date":"2024-03-08","current":-5.007249,"twenty":-14.62577,"median":-9.833927,"eighty":-5.587439,"marketCap":1495704513},{"date":"2024-03-15","current":-4.865359,"twenty":-14.61207,"median":-9.76953,"eighty":-5.567433,"marketCap":1452034308},{"date":"2024-03-22","current":-5.382425,"twenty":-14.606007,"median":-9.684863,"eighty":-5.542667,"marketCap":1604880024},{"date":"2024-03-28","current":-6.471617,"twenty":-14.596766,"median":-9.6313,"eighty":-5.538679,"marketCap":1703137985},{"date":"2024-04-05","current":-6.805541,"twenty":-14.59363,"median":-9.596323,"eighty":-5.544948,"marketCap":1790478395},{"date":"2024-04-12","current":-7.506731,"twenty":-14.592289,"median":-9.582636,"eighty":-5.549891,"marketCap":1976076765},{"date":"2024-04-19","current":-7.845218,"twenty":-14.587772,"median":-9.509145,"eighty":-5.557524,"marketCap":2063417174},{"date":"2024-04-26","current":-7.896463,"twenty":-14.578925,"median":-9.436926,"eighty":-5.566301,"marketCap":2074334726},{"date":"2024-05-03","current":-7.860336,"twenty":-14.573204,"median":-9.382005,"eighty":-5.567444,"marketCap":2063417174},{"date":"2024-05-10","current":-7.675757,"twenty":-14.563974,"median":-9.240993,"eighty":-5.569089,"marketCap":2019746970},{"date":"2024-05-17","current":-7.396179,"twenty":-14.56342,"median":-9.187914,"eighty":-5.575495,"marketCap":1943324111},{"date":"2024-05-24","current":-8.037809,"twenty":-14.531177,"median":-9.069449,"eighty":-5.582295,"marketCap":2107087379},{"date":"2024-05-31","current":-7.738407,"twenty":-14.480405,"median":-8.990305,"eighty":-5.587439,"marketCap":2030664521},{"date":"2024-06-07","current":-7.248143,"twenty":-14.467448,"median":-8.924233,"eighty":-5.592398,"marketCap":1899653907},{"date":"2024-06-14","current":-7.171402,"twenty":-14.419922,"median":-8.847943,"eighty":-5.59554,"marketCap":1877818804},{"date":"2024-06-21","current":-6.935757,"twenty":-14.35206,"median":-8.704335,"eighty":-5.604323,"marketCap":1812313497},{"date":"2024-06-28","current":-7.022233,"twenty":-14.336471,"median":-8.492709,"eighty":-5.607081,"marketCap":1834148599},{"date":"2024-07-05","current":-6.856527,"twenty":-14.328858,"median":-8.376987,"eighty":-5.611504,"marketCap":1790478395},{"date":"2024-07-12","current":-7.013456,"twenty":-14.30467,"median":-8.326629,"eighty":-5.617396,"marketCap":1834148599},{"date":"2024-07-19","current":-6.554119,"twenty":-14.290694,"median":-8.30121,"eighty":-5.625597,"marketCap":1714055536},{"date":"2024-07-26","current":-6.654635,"twenty":-14.285804,"median":-8.255353,"eighty":-5.635396,"marketCap":1746808190},{"date":"2024-08-02","current":-6.783362,"twenty":-14.277131,"median":-8.215302,"eighty":-5.643728,"marketCap":1779560843},{"date":"2024-08-09","current":-6.614431,"twenty":-14.234116,"median":-8.193349,"eighty":-5.650585,"marketCap":1746808190},{"date":"2024-08-16","current":-6.446564,"twenty":-14.191312,"median":-8.188382,"eighty":-5.653141,"marketCap":1703137985},{"date":"2024-08-23","current":-6.56458,"twenty":-14.177716,"median":-8.149928,"eighty":-5.653426,"marketCap":1430199205},{"date":"2024-08-30","current":-6.321694,"twenty":-14.158701,"median":-8.105511,"eighty":-5.655741,"marketCap":1386529001},{"date":"2024-09-06","current":-5.721612,"twenty":-14.142552,"median":-8.055097,"eighty":-5.660287,"marketCap":1255518386},{"date":"2024-09-13","current":-6.085816,"twenty":-14.137983,"median":-8.032869,"eighty":-5.662843,"marketCap":1331941245},{"date":"2024-09-20","current":-6.099124,"twenty":-14.136128,"median":-8.002056,"eighty":-5.663724,"marketCap":1342858796},{"date":"2024-09-27","current":-6.111953,"twenty":-14.132785,"median":-7.980325,"eighty":-5.672567,"marketCap":1353776347},{"date":"2024-10-04","current":-6.090326,"twenty":-14.125857,"median":-7.967369,"eighty":-5.685123,"marketCap":1342858796},{"date":"2024-10-10","current":-6.825013,"twenty":-14.110707,"median":-7.909429,"eighty":-5.687411,"marketCap":1495704513},{"date":"2024-10-18","current":-6.96373,"twenty":-14.109239,"median":-7.894808,"eighty":-5.68757,"marketCap":1517539615},{"date":"2024-10-25","current":-6.863968,"twenty":-14.101553,"median":-7.887625,"eighty":-5.688686,"marketCap":1495704513},{"date":"2024-11-01","current":-6.258525,"twenty":-14.091231,"median":-7.876326,"eighty":-5.702032,"marketCap":1364693898},{"date":"2024-11-08","current":-6.154956,"twenty":-14.089073,"median":-7.847489,"eighty":-5.702032,"marketCap":1331941245},{"date":"2024-11-15","current":-5.89682,"twenty":-14.011082,"median":-7.738407,"eighty":-5.702032,"marketCap":1266435938},{"date":"2024-11-22","current":-5.696759,"twenty":-13.916278,"median":-7.696764,"eighty":-5.696759,"marketCap":1222765733},{"date":"2024-11-29","current":-5.394645,"twenty":-13.832055,"median":-7.596958,"eighty":-5.664577,"marketCap":1157260426},{"date":"2024-12-06","current":-5.458395,"twenty":-13.711835,"median":-7.485856,"eighty":-5.653616,"marketCap":1168177977},{"date":"2024-12-13","current":-5.673645,"twenty":-13.553001,"median":-7.352815,"eighty":-5.653141,"marketCap":1211848182},{"date":"2024-12-20","current":-5.390849,"twenty":-13.519899,"median":-7.248143,"eighty":-5.614983,"marketCap":1146342874},{"date":"2024-12-27","current":-5.65194,"twenty":-13.458044,"median":-7.171402,"eighty":-5.614326,"marketCap":1200930630},{"date":"2025-01-03","current":-5.184433,"twenty":-13.405799,"median":-7.104086,"eighty":-5.600887,"marketCap":1102672670},{"date":"2025-01-10","current":-5.152626,"twenty":-13.361795,"median":-7.069649,"eighty":-5.582295,"marketCap":1091755119},{"date":"2025-01-17","current":-5.148471,"twenty":-13.336569,"median":-7.026933,"eighty":-5.552175,"marketCap":1091755119},{"date":"2025-01-24","current":-5.167576,"twenty":-13.222993,"median":-7.013456,"eighty":-5.514572,"marketCap":1102672670},{"date":"2025-01-28","current":-5.140636,"twenty":-13.208359,"median":-6.990621,"eighty":-5.503528,"marketCap":1102672670},{"date":"2025-02-07","current":-5.27226,"twenty":-13.135783,"median":-6.94846,"eighty":-5.495097,"marketCap":1124507772},{"date":"2025-02-14","current":-5.644048,"twenty":-13.022037,"median":-6.899379,"eighty":-5.48863,"marketCap":1200930630},{"date":"2025-02-21","current":-5.307084,"twenty":-12.940412,"median":-6.85645,"eighty":-5.475956,"marketCap":1135425323},{"date":"2025-02-28","current":-5.939013,"twenty":-12.867839,"median":-6.83647,"eighty":-5.468291,"marketCap":1266435938},{"date":"2025-03-07","current":-6.119239,"twenty":-12.809466,"median":-6.804007,"eighty":-5.467568,"marketCap":1310106142},{"date":"2025-03-14","current":-5.964088,"twenty":-12.763824,"median":-6.770661,"eighty":-5.467568,"marketCap":1277353489},{"date":"2025-03-21","current":-6.272401,"twenty":-12.722881,"median":-6.714298,"eighty":-5.467568,"marketCap":1342858796},{"date":"2025-03-28","current":-6.898302,"twenty":-12.722881,"median":-6.670615,"eighty":-5.467568,"marketCap":1473869410},{"date":"2025-04-03","current":-7.011472,"twenty":-12.722881,"median":-6.642295,"eighty":-5.467568,"marketCap":1386529001},{"date":"2025-04-11","current":-6.280275,"twenty":-12.722881,"median":-6.610673,"eighty":-5.467568,"marketCap":1233683284},{"date":"2025-04-17","current":-6.819691,"twenty":-12.721837,"median":-6.592748,"eighty":-5.468291,"marketCap":1342858796},{"date":"2025-04-25","current":-7.256981,"twenty":-12.723926,"median":-6.571402,"eighty":-5.466844,"marketCap":1430199205},{"date":"2025-05-02","current":-8.73413,"twenty":-12.722881,"median":-6.57172,"eighty":-5.467568,"marketCap":1724973088},{"date":"2025-05-09","current":-7.136212,"twenty":-12.723926,"median":-6.571402,"eighty":-5.466844,"marketCap":1419281654},{"date":"2025-05-16","current":-7.078383,"twenty":-12.723926,"median":-6.571402,"eighty":-5.466844,"marketCap":1419281654},{"date":"2025-05-23","current":-6.948699,"twenty":-12.626269,"median":-6.571402,"eighty":-5.466844,"marketCap":1397446552},{"date":"2025-05-30","current":-7.999265,"twenty":-12.463363,"median":-6.56664,"eighty":-5.466844,"marketCap":1615797576},{"date":"2025-06-06","current":-12.669712,"twenty":-12.457434,"median":-6.56664,"eighty":-5.466844,"marketCap":2565725443},{"date":"2025-06-13","current":-14.210631,"twenty":-12.612398,"median":-6.56664,"eighty":-5.466844,"marketCap":2878912587},{"date":"2025-06-20","current":-12.510851,"twenty":-12.558798,"median":-6.56664,"eighty":-5.466844,"marketCap":2529588465},{"date":"2025-06-27","current":-11.34714,"twenty":-12.552983,"median":-6.5687,"eighty":-5.467568,"marketCap":2300720937},{"date":"2025-07-04","current":-12.118889,"twenty":-12.471396,"median":-6.5687,"eighty":-5.467568,"marketCap":2457314509},{"date":"2025-07-11","current":-11.95271,"twenty":-12.404868,"median":-6.5687,"eighty":-5.467568,"marketCap":2421177531},{"date":"2025-07-18","current":-15.651881,"twenty":-12.404868,"median":-6.5687,"eighty":-5.467568,"marketCap":3168008411},{"date":"2025-07-25","current":-19.153,"twenty":-12.471396,"median":-6.5687,"eighty":-5.467568,"marketCap":3890747973},{"date":"2025-08-01","current":-18.615757,"twenty":-12.640326,"median":-6.5687,"eighty":-5.467568,"marketCap":3758245720},{"date":"2025-08-08","current":-17.200416,"twenty":-12.738412,"median":-6.5687,"eighty":-5.467568,"marketCap":3481195555},{"date":"2025-08-15","current":-21.041033,"twenty":-12.774326,"median":-6.5687,"eighty":-5.467568,"marketCap":4252117754},{"date":"2025-08-22","current":-18.790719,"twenty":-12.888016,"median":-6.5687,"eighty":-5.467568,"marketCap":3785450762},{"date":"2025-08-29","current":-15.943312,"twenty":-13.023275,"median":-6.5687,"eighty":-5.467568,"marketCap":3227164858},{"date":"2025-09-05","current":-20.757694,"twenty":-13.176303,"median":-6.5687,"eighty":-5.467568,"marketCap":3272466472},{"date":"2025-09-12","current":-15.628094,"twenty":-13.244692,"median":-6.5687,"eighty":-5.467568,"marketCap":2468216238},{"date":"2025-09-19","current":-16.869242,"twenty":-13.354631,"median":-6.5687,"eighty":-5.467568,"marketCap":2662345605},{"date":"2025-09-26","current":-15.503696,"twenty":-13.402244,"median":-6.5687,"eighty":-5.467568,"marketCap":2440483471},{"date":"2025-10-03","current":-16.433457,"twenty":-13.441102,"median":-6.569892,"eighty":-5.468291,"marketCap":2593013688},{"date":"2025-10-10","current":-15.577362,"twenty":-13.522687,"median":-6.5687,"eighty":-5.467568,"marketCap":2454349854},{"date":"2025-10-17","current":-13.739896,"twenty":-13.565862,"median":-6.5687,"eighty":-5.467568,"marketCap":2163155804},{"date":"2025-10-24","current":-13.558813,"twenty":-13.693116,"median":-6.5687,"eighty":-5.467568,"marketCap":2135423037},{"date":"2025-10-31","current":-14.329838,"twenty":-13.753461,"median":-6.5687,"eighty":-5.467568,"marketCap":2260220487},{"date":"2025-11-07","current":-14.426762,"twenty":-13.841138,"median":-6.5687,"eighty":-5.467568,"marketCap":2274086871},{"date":"2025-11-14","current":-15.78951,"twenty":-13.942615,"median":-6.5687,"eighty":-5.467568,"marketCap":2495949004},{"date":"2025-11-21","current":-14.129422,"twenty":-14.006324,"median":-6.5687,"eighty":-5.467568,"marketCap":2232487720},{"date":"2025-11-28","current":-13.378743,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2121556654},{"date":"2025-12-05","current":-13.181195,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2093823887},{"date":"2025-12-12","current":-13.069727,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2079957504},{"date":"2025-12-19","current":-12.865144,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2052224737},{"date":"2025-12-24","current":-12.825196,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2052224737},{"date":"2026-01-02","current":-11.998065,"twenty":-14.010364,"median":-6.56664,"eighty":-5.466844,"marketCap":1927427287},{"date":"2026-01-09","current":-14.723549,"twenty":-14.053942,"median":-6.56664,"eighty":-5.466844,"marketCap":2371151554},{"date":"2026-01-16","current":-12.358616,"twenty":-14.084528,"median":-6.56664,"eighty":-5.466844,"marketCap":1996759203},{"date":"2026-01-23","current":-12.370484,"twenty":-14.084528,"median":-6.56664,"eighty":-5.466844,"marketCap":1996759203},{"date":"2026-01-30","current":-11.630068,"twenty":-14.084528,"median":-6.56664,"eighty":-5.466844,"marketCap":1885828136},{"date":"2026-02-06","current":-14.244909,"twenty":-14.090415,"median":-6.56664,"eighty":-5.466844,"marketCap":2315686021},{"date":"2026-02-13","current":-16.029413,"twenty":-14.132571,"median":-6.5687,"eighty":-5.467568,"marketCap":2620746455},{"date":"2026-02-20","current":-16.98681,"twenty":-14.145589,"median":-6.56458,"eighty":-5.466121,"marketCap":2773276672},{"date":"2026-02-27","current":-16.970561,"twenty":-14.207782,"median":-6.56458,"eighty":-5.466121,"marketCap":2801009438},{"date":"2026-03-06","current":-16.515615,"twenty":-14.281053,"median":-6.56458,"eighty":-5.466121,"marketCap":2703944755},{"date":"2026-03-13","current":-14.500832,"twenty":-14.334826,"median":-6.56458,"eighty":-5.466121,"marketCap":2385017937},{"date":"2026-03-20","current":-14.302066,"twenty":-14.404725,"median":-6.56458,"eighty":-5.466121,"marketCap":2343418787},{"date":"2026-03-27","current":-20.530075,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2440483471},{"date":"2026-04-02","current":-20.431884,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2440483471},{"date":"2026-04-10","current":-18.777882,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2260220487},{"date":"2026-04-17","current":-18.194234,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2190888570},{"date":"2026-04-24","current":-17.041733,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2052224737},{"date":"2026-04-30","current":-17.267598,"twenty":-14.418248,"median":-6.56458,"eighty":-5.466121,"marketCap":2079957504},{"date":"2026-05-08","current":-16.290118,"twenty":-14.467448,"median":-6.563413,"eighty":-5.465398,"marketCap":1969026437},{"date":"2026-05-15","current":-14.988785,"twenty":-14.531177,"median":-6.563413,"eighty":-5.465398,"marketCap":1816496220},{"date":"2026-05-22","current":-15.481839,"twenty":-14.571639,"median":-6.56458,"eighty":-5.466121,"marketCap":1871961753},{"date":"2026-05-29","current":-14.171079,"twenty":-14.581223,"median":-6.563413,"eighty":-5.465398,"marketCap":1719431536},{"date":"2026-06-05","current":-13.465839,"twenty":-14.581223,"median":-6.563413,"eighty":-5.465398,"marketCap":1636233236},{"date":"2026-06-12","current":-14.731093,"twenty":-14.59239,"median":-6.563413,"eighty":-5.465398,"marketCap":1788763453},{"date":"2026-06-18","current":-13.218654,"twenty":-14.59234,"median":-6.56458,"eighty":-5.466121,"marketCap":1608500469},{"date":"2026-06-26","current":-11.448026,"twenty":-14.59239,"median":-6.563413,"eighty":-5.465398,"marketCap":1386638336},{"date":"2026-07-03","current":-14.871309,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1802629836},{"date":"2026-07-10","current":-13.629694,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1650099619},{"date":"2026-07-17","current":-12.782457,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1553034936},{"date":"2026-07-24","current":-13.692413,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1663966003},{"date":"2026-07-31","current":-15.488645,"twenty":-14.607478,"median":-6.562246,"eighty":-5.465196,"marketCap":1885828136},{"date":"2026-08-07","current":-15.231297,"twenty":-14.723549,"median":-6.562246,"eighty":-5.465196,"marketCap":1858095370},{"date":"2026-08-14","current":-13.849766,"twenty":-14.723694,"median":-6.562246,"eighty":-5.465196,"marketCap":1691698769},{"date":"2026-08-21","current":-12.686502,"twenty":-14.723694,"median":-6.562246,"eighty":-5.465196,"marketCap":1553034936},{"date":"2026-08-28","current":-12.174017,"twenty":-14.61481,"median":-6.562246,"eighty":-5.465196,"marketCap":1490636211}],"updateTime":1788186599501},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03681\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127081164","title":"Sinomab Bioscience Maintains 1.39 Billion Outstanding Shares in March 2026, Grants 11.57 Million New Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1127081164","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127081164?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:22","pubTimestamp":1775640146,"startTime":"0","endTime":"0","summary":"Sinomab Bioscience Limited reported no change in its share capital for the month ended 31 March 2026. The number of issued ordinary shares remained at 1.39 billion, and the company held no treasury...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624688186","title":"BRIEF-Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2624688186","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624688186?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:31","pubTimestamp":1775223071,"startTime":"0","endTime":"0","summary":"BRIEF-Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience  April 3 (Reuters) - Hainan Haiyao Co Ltd 000566.SZ:SAYS CO PLANS TO UNLOAD UP TO 5% STAKE IN SINOMAB BIOSCIENCE LTDSource textFurther company coverage: 000566.SZ (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nL4N40M0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0188","BK0146","BK0070","BK0060","03681","000566","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624668891","title":"Hainan Haiyao  Says Co Plans to Unload up to 5% Stake in SinoMab BioScience Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2624668891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624668891?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:31","pubTimestamp":1775223071,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nL4N40M0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03681","BK0070","BK0188","BK1161","BK0239","000566","BK0146","BK0060","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116443811","title":"SM17 Phase 2 Trial for Atopic Dermatitis Administers First Dose in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1116443811","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116443811?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:54","pubTimestamp":1775037289,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) has announced that on March 31, 2026, the first patient in its Phase 2 clinical trial for SM17 in treating atopic dermatitis was successfully dosed in China. This Phase 2 study...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","03681","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591953","title":"SinoMab doses first patient in China Phase 2 trial of SM17 for atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624591953?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:47","pubTimestamp":1775036857,"startTime":"0","endTime":"0","summary":"SinoMab BioScience dosed first patient on March 31, 2026 in a Phase 2 China trial of SM17 for moderate-to-severe atopic dermatitis.Study will test subcutaneous SM17 across multiple dose groups versus placebo in about 210 patients, with readouts planned through Week 24.Program follows previously presented positive Phase 1b topline results in atopic dermatitis, supporting continued development for both itch relief and skin improvement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6dPlN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624584965","title":"SinoMab BioScience says non-executive directors Chen, Dong resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2624584965","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624584965?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:59","pubTimestamp":1774990769,"startTime":"0","endTime":"0","summary":"SinoMab BioScience said non-executive director Haigang Chen will step down effective March 31, 2026.Non-executive director Xun Dong will resign effective April 1, 2026.Board will retain Shui On Leung as executive director, chairman, and CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLcb3DmH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624452558","title":"SinoMab BioScience files list of directors with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2624452558","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624452558?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:58","pubTimestamp":1774990717,"startTime":"0","endTime":"0","summary":"SinoMab BioScience filed updated board composition for Hong Kong Stock Exchange, naming Shui On Leung as chairman and chief executive officer.Board includes two non-executive directors, including Xun Dong.Board includes five independent non-executive directors, including Ping Cho Terence Hon.Hon chairs audit committee; Chi Ming Lee chairs remuneration committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLHTsdT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175147246","title":"SinoMab Announces Resignation of Two Non-Executive Directors Effective March–April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1175147246","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175147246?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:27","pubTimestamp":1774952869,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited reported that non-executive directors Dr. Haigang Chen and Mr. Xun Dong have submitted their resignations, citing personal and business commitments. Dr. Chen’s resignation...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170105062","title":"SinoMab Announces Updated Board Composition and Committee Assignments","url":"https://stock-news.laohu8.com/highlight/detail?id=1170105062","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170105062?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:23","pubTimestamp":1774952635,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited disclosed an updated roster of its Board of Directors, highlighting current roles and committee memberships as of 31 March 2026. The Board now comprises one executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107449274","title":"SINOMAB BIO-B Announces Resignation of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1107449274","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107449274?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:07","pubTimestamp":1774951661,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) has announced that Dr. Chen Haigang has submitted his resignation as a non-executive director, effective March 31, 2026, in order to devote more time to personal matters....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102149296","title":"SinoMab Announces Positive Phase 1 Bridging Data for Subcutaneous SM17, Preparing Phase 2 Atopic Dermatitis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1102149296","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102149296?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:03","pubTimestamp":1774432989,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited disclosed encouraging topline results from a Phase 1 bridging study assessing the subcutaneous (SC) formulation of its first-in-class monoclonal antibody SM17 in mainland...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186285600","title":"Positive Topline Results from SM17 Route Conversion Phase 1 Bridging Study in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1186285600","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186285600?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:01","pubTimestamp":1774432870,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) has announced that its SM17 drug candidate has achieved positive topline results in a Phase 1 bridging study in China evaluating a route of administration conversion. The first...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622021012","title":"SinoMab BioScience announces positive topline results for SM17 China Phase 1 route-switch bridging study; AD Phase 2 in China expected to start by mid-FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622021012","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622021012?lang=en_us&edition=fundamental","pubTime":"2026-03-25 17:51","pubTimestamp":1774432301,"startTime":"0","endTime":"0","summary":"SinoMab BioScience announces positive topline results for SM17 China Phase 1 route-switch bridging study; AD Phase 2 in China expected to start by mid-FY2026. SinoMab BioScience reported positive topline results from a China Phase 1 bridging study that supports switching SM17 to a subcutaneous formulation, a step that could improve convenience and strengthen its positioning in inflammatory and immune diseases.The randomized, double-blind, placebo-controlled trial enrolled 30 healthy participants and reported no serious adverse events, while injection-site reactions were limited to one Grade 1 rash that resolved within one hour.The company said the subcutaneous formulation showed predictable pharmacokinetics and competitive absolute bioavailability, supporting a stable route-of-administration transition and potentially broadening commercialization options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL43HMBh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165770707","title":"SINOMAB BIO-B (03681) Grants 11.5748 Million Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1165770707","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165770707?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:02","pubTimestamp":1774353762,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) announced that on March 24, 2026, the company granted 11.5748 million share options to two eligible individuals under the 2022 Share Option Scheme. These options grant the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113965597","title":"SinoMab Grants 11.57 Million Share Options at HK$1.94 to Two Employees, Including One Senior Manager","url":"https://stock-news.laohu8.com/highlight/detail?id=1113965597","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113965597?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:02","pubTimestamp":1774353729,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited announced the grant of 11.57 million share options on 24 March 2026 under its 2022 Share Option Scheme, which was adopted on 26 October 2022 and amended on 14 June 2024....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621061424","title":"SinoMab grants 11,574,840 share options at HKD 1.94 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061424","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061424?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:50","pubTimestamp":1774353055,"startTime":"0","endTime":"0","summary":"SinoMab BioScience granted 11,574,840 share options to two employees, including one senior management member.The exercise price was set at HKD 1.94 per share.Options for the senior management grantee are exercisable from March 25, 2027 to March 24, 2036.Options for the other employee are exercisable from March 25, 2028 to March 24, 2036.The vesting schedule provides 25% tranches, with the senior management grant vesting through March 25, 2030 and the other employee grant vesting through March 25, 2031.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 24, 2026,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL8cT17Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621037314","title":"SinoMab BioScience's 2025 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2621037314","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621037314?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:36","pubTimestamp":1774323364,"startTime":"0","endTime":"0","summary":"SinoMab BioScience  booked 105 million yuan in attributable loss for 2025, narrowing from 185.1 million yuan in 2024, according to a Hong Kong bourse filing Monday.Shares of the firm gained over 1% in morning trade Tuesday.Loss per share was 0.09 yuan, compared with 0.17 yuan in the prior year.The company did not generate any revenue during the year. SinoMab recorded 2 million yuan in sales for 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621128707","title":"BRIEF-Sinomab Bioscience Posts Loss For Year Rmb105.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621128707","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621128707?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:25","pubTimestamp":1774279556,"startTime":"0","endTime":"0","summary":"BRIEF-Sinomab Bioscience Posts Loss For Year Rmb105.0 MillionMarch 23 (Reuters) - SinoMab BioScience Ltd 3681.HK:LOSS FOR YEAR RMB105.0 MILLIONFurther company coverage: 3681.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108253845","title":"SINOMAB BIO-B (03681) Reports Significant Narrowing of Losses in 2025, Major Strides in Pipeline Development and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=1108253845","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108253845?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:54","pubTimestamp":1774277666,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) announced its 2025 financial results, with other income and gains reaching approximately RMB 29.271 million, a year-on-year increase of 2.84 times. Research and development...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621351704","title":"SinoMab FY2025 loss narrows 43.3% to RMB105 million, total funding available jumps 148.5% to RMB351 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621351704","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621351704?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:17","pubTimestamp":1774275473,"startTime":"0","endTime":"0","summary":"SinoMab published an annual results announcement for the year ended Dec. 31, 2025, including a change in use of proceeds.Loss for the year was RMB105.0 million, a 43.3% decrease.Total funding available to use was RMB351.5 million, more than doubled, reflecting share subscription proceeds and partially offset by bank borrowing repayments, operating cash outflows and capital expenditures.Net cash used in operating activities was RMB70.48 million, while net cash from financing activities was RMB329.39 million.Business updates included positive Phase 1b topline results for SM17 in atopic dermatitis, initiation of a Phase 1 bridging study for subcutaneous administration, and NMPA acceptance of an SM17 IND for inflammatory bowel disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL9DY9rX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","03681"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":67,"code":"91000000","status":"200"}]}}